SI-BONE Stock

SI-BONE EBIT

The EBIT of SI-BONE (SIBN) as of Aug 6, 2026 is -22.33 M USD. In the previous year, EBIT was -35.25 M USD — a change of -36.65% (higher).

EBIT

-22.33 MUSD

YoY

-36.65%

Last updated:

In 2026, SI-BONE's EBIT was -22.33 M USD, a -36.65% increase from the -35.25 M USD EBIT recorded in the previous year.

The SI-BONE EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT (M USD)
Date
EBIT (M USD)
Jan 1, 2023
-46.93 base
Jan 1, 2024
-35.25 base
Jan 1, 2025
-22.33 base
Jan 1, 2026 (e)
87.49 base
Jan 1, 2027 (e)
100.70 base
Jan 1, 2028 (e)
115.31 base
Jan 1, 2029 (e)
132.28 base
Jan 1, 2030 (e)
151.12 base
YEAREBIT (M USD)
2030 est 151.12
2029 est 132.28
2028 est 115.31
2027 est 100.70
2026 est 87.49
2025 -22.33
2024 -35.25
2023 -46.93
2022 -59.74
2021 -53.06
2020 -38.69
2019 -36.01
2018 -13.11
2017 -17.01
2016 -17.35
2015 -26.42
2014 -26.30
2013 -5.30
2012 -10.72
Access this data via the Eulerpool API

SI-BONE Revenue

SI-BONE Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2023
138.89 M USD
-46.93 M USD
-43.34 M USD
Jan 1, 2024
167.18 M USD
-35.25 M USD
-30.91 M USD
Jan 1, 2025
200.93 M USD
-22.33 M USD
-18.91 M USD
Jan 1, 2026 (e)
231.62 M USD
87.49 M USD
-19.21 M USD
Jan 1, 2027 (e)
266.61 M USD
100.70 M USD
-16.02 M USD
Jan 1, 2028 (e)
305.28 M USD
115.31 M USD
-10.38 M USD
Jan 1, 2029 (e)
350.20 M USD
132.28 M USD
2.21 M USD
Jan 1, 2030 (e)
400.10 M USD
151.12 M USD
14.13 M USD

SI-BONE Margins

SI-BONE stock margins

The SI-BONE margin analysis displays the gross margin, EBIT margin, as well as the profit margin of SI-BONE. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for SI-BONE.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2023
78.78 %
-33.79 %
-31.20 %
Jan 1, 2024
79.03 %
-21.08 %
-18.49 %
Jan 1, 2025
79.57 %
-11.11 %
-9.41 %
Jan 1, 2026 (e)
79.57 %
37.77 %
-8.29 %
Jan 1, 2027 (e)
79.57 %
37.77 %
-6.01 %
Jan 1, 2028 (e)
79.57 %
37.77 %
-3.40 %
Jan 1, 2029 (e)
79.57 %
37.77 %
0.63 %
Jan 1, 2030 (e)
79.57 %
37.77 %
3.53 %

SI-BONE Stock analysis

What does SI-BONE do? SI-BONE Inc. is an innovative medical technology company based in Santa Clara, California. It was founded in 2008 by a group of orthopedic surgeons, engineers, and entrepreneurs who aimed to improve the treatment of lower back pain. The company is now globally recognized and specializes in the development and marketing of implants for the treatment of pain and discomfort in the pelvic and back areas. SI-BONE focuses on the treatment of pain and discomfort in the pelvic and back areas, offering a range of products for this purpose. The company's main focus is on the development of innovative implants that can be used minimally invasively, with the goal of providing patients with quick recovery and improved quality of life. The flagship product of SI-BONE is the iFuse implant. This implant is used in patients with chronic lower back pain caused by instability of the spine or pelvis. The iFuse implant stabilizes the pelvis and thereby reduces the pain originating from the unstable joint region. The iFuse implant has been FDA approved and is now available in over 40 countries worldwide. In addition to the iFuse implant, SI-BONE also offers a variety of other products tailored to the needs of physicians and patients. These include implantable instruments and consumables such as bone screws or arthroscopy needles. SI-BONE is a publicly traded company listed on NASDAQ under the ticker symbol "SIBN." The company's business model is based on providing innovative products to physicians and hospitals that optimize the treatment of back pain. To achieve this, SI-BONE works closely with leading industry professionals to enable optimal treatment of back pain. SI-BONE has established itself as a strong, innovative company specializing in minimally invasive implants in the field of pain therapy. Through close collaboration with physicians and specialists and investment in research and development of cutting-edge technologies, SI-BONE aims to continue growing and achieve a leading position in the field of pain therapy. SI-BONE is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing SI-BONE's EBIT

SI-BONE's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of SI-BONE's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

SI-BONE's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in SI-BONE’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about SI-BONE stock

EBIT of SI-BONE is -22.33 M USD in 2026.

EBIT of SI-BONE changed from -35.25 M USD to -22.33 M USD, representing a -36.65% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT SI-BONE since 2006 – with annual values, charts, and detailed analysis.

"Earnings before interest and taxes", abbreviated as EBIT, is also referred to as the operating result of a company. It is a key figure that allows the profit to be assessed over a specific period of time, usually a fiscal year. Taxes and interest are not deducted from EBIT, making it suitable for international comparisons of different companies.

Net income
+ Tax expense
+ Interest expense and other financial expenses
- Interest income and other financial income
= EBIT (operating profit)

EBIT's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT's SI-BONE historically and in real time.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

Income Statement — SI-BONE

All Key Metrics — SI-BONE